| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
2,970,000 |
| Market
Cap: |
1.11(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.3751 - $0.3751 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile OncoSec Medical is a immuno-oncology company focused on designing, developing and commercializing intra-tumoral DNA-based therapeutics to stimulate and to guide anti-tumor immune responses for the treatment of cancers. Co.'s main technology platform ImmunoPulse® is a drug-device therapeutic modality platform comprised of proprietary intratumoral electroporation (EP) delivery devices (the OncoSec Medical System (OMS) EP Device) and a proprietary DNA plasmid. The OMS EP Device is designed to deliver plasmid DNA-encoded drugs into a solid tumor and promote an immunological response against cancer. Co.'s main product candidate is a DNA-encoded interleukin-12 called tavokinogene telseplasmid.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
607 |
| Total Sell Value |
$0 |
$0 |
$0 |
$362 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
3 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Delaversano Robert J |
VP, Finance |
• – – |
2023-02-09 |
4 |
S |
$1.37 |
$55 |
D/D |
(40) |
1,008 |
|
- |
|
| Delaversano Robert J |
VP, Finance |
• – – |
2022-11-04 |
4 |
S |
$0.37 |
$105 |
D/D |
(283) |
22,975 |
|
- |
|
| Delaversano Robert J |
VP, Finance |
• – – |
2022-08-05 |
4 |
S |
$0.71 |
$202 |
D/D |
(284) |
23,258 |
|
- |
|
| Delaversano Robert J |
VP, Finance |
• – – |
2022-02-09 |
4 |
S |
$0.88 |
$360 |
D/D |
(409) |
23,816 |
|
- |
|
| Delaversano Robert J |
VP, Finance |
• – – |
2021-11-01 |
4 |
S |
$1.75 |
$600 |
D/D |
(343) |
24,225 |
|
- |
|
| Dalesandro Margaret |
Director |
– • – |
2021-08-23 |
4 |
B |
$1.89 |
$37,800 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
| Zhao Yuhang |
Director |
– • – |
2021-08-23 |
4 |
B |
$1.88 |
$7,520 |
D/D |
4,000 |
12,000 |
2.39 |
- |
|
| Zhao Yuhang |
Director |
– • – |
2021-08-20 |
4 |
B |
$1.94 |
$15,520 |
D/D |
8,000 |
8,000 |
2.39 |
- |
|
| Delaversano Robert J |
VP, Finance |
• – – |
2021-08-02 |
4 |
S |
$2.18 |
$898 |
D/D |
(412) |
24,568 |
|
- |
|
| Leuthner Brian A |
Interim CEO |
• – – |
2021-06-28 |
4 |
S |
$3.16 |
$43,017 |
D/D |
(13,613) |
178,387 |
|
- |
|
| Leuthner Brian A |
Interim CEO |
• – – |
2021-06-28 |
4 |
A |
$0.00 |
$0 |
D/D |
192,000 |
192,000 |
|
- |
|
| Delaversano Robert J |
VP, Finance |
• – – |
2021-05-03 |
4 |
S |
$4.86 |
$2,202 |
D/D |
(453) |
24,980 |
|
- |
|
| O'connor Daniel |
CEO and President |
• • – |
2021-04-30 |
4 |
S |
$4.86 |
$15,416 |
D/D |
(3,172) |
96,097 |
|
- |
|
| Sirtex Medical Us Holdings, Inc. |
See Remarks |
– – • |
2021-04-16 |
4 |
B |
$3.45 |
$5,836,731 |
I/I |
1,691,806 |
3,359,607 |
1.5 |
- |
|
| Alpha Holdings, Inc. |
Director |
– • – |
2021-02-18 |
4 |
OE |
$3.45 |
$1,270,463 |
D/D |
368,250 |
1,718,251 |
|
- |
|
| Delaversano Robert J |
Principal Accounting Officer |
• – – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,750 |
25,433 |
|
- |
|
| O'connor Daniel |
CEO and President |
• • – |
2021-02-01 |
4 |
S |
$7.71 |
$26,314 |
D/D |
(3,413) |
99,269 |
|
- |
|
| Sirtex Medical Us Holdings, Inc. |
See Remarks |
– – • |
2021-01-25 |
4 |
B |
$5.45 |
$22,165,352 |
I/I |
4,067,037 |
3,077,639 |
1.5 |
- |
|
| Alpha Holdings, Inc. |
Director |
– • – |
2020-11-20 |
4 |
S |
$4.92 |
$393,872 |
D/D |
(80,000) |
1,350,001 |
|
- |
|
| Alpha Holdings, Inc. |
Director |
– • – |
2020-11-19 |
4 |
S |
$5.10 |
$255,230 |
D/D |
(50,000) |
1,430,001 |
|
- |
|
| Alpha Holdings, Inc. |
Director |
– • – |
2020-11-18 |
4 |
S |
$5.24 |
$57,652 |
D/D |
(10,999) |
1,480,001 |
|
- |
|
| Alpha Holdings, Inc. |
Director |
– • – |
2020-11-18 |
4 |
S |
$5.24 |
$209,664 |
I/I |
(40,000) |
1,491,000 |
|
- |
|
| Alpha Holdings, Inc. |
Director |
– • – |
2020-11-17 |
4 |
S |
$5.17 |
$206,744 |
I/I |
(40,000) |
1,531,000 |
|
- |
|
| Alpha Holdings, Inc. |
Director |
– • – |
2020-11-16 |
4 |
S |
$5.41 |
$216,328 |
I/I |
(40,000) |
1,571,000 |
|
- |
|
| O'connor Daniel |
CEO and President |
• • – |
2020-11-02 |
4 |
S |
$3.79 |
$12,431 |
D/D |
(3,280) |
102,682 |
|
- |
|
108 Records found
|
|
Page 1 of 5 |
|
|
